期刊文献+

细胞外基质和整合素β1在非小细胞肺癌中的表达和意义 被引量:3

Immuno-histochemical Expression and Significance of Extracellular Matrix Proteins and Integrin β1 in Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的 研究细胞外基质中纤维黏连蛋白、Ⅳ型胶原蛋白、层黏连蛋白和整合素β1在人非小细胞肺癌组织中 的表达特征及意义。方法 采用免疫组化En Vision法,检测57例非小细胞肺癌组织中细胞外基质和整合素β1的 表达。结果 在非小细胞肺癌中纤维黏连蛋白、Ⅳ型胶原蛋白、层黏连蛋白广泛(≥50%切片区域)表达率分别为 80.7%、71.9%和42.1%,整合素β1阳性表达率为43.9%。纤维黏连蛋白、Ⅳ型胶原蛋白、层黏连蛋白和整合素β1 在57例肿瘤标本中阳性表达率显著高于在23例正常肺组织的阳性表达率(P<O.05)。在非小细胞肺癌中,层黏 连蛋白在中高分化组的阳性表达率显著高于低分化组(P<0.05)。Ⅳ型胶原蛋白在肺腺癌表达率显著高于在肺鳞 癌的表达率(P<0.05);层黏连蛋白在肺鳞癌的表达率显著高于在肺腺癌表达率(P<0.05)。无淋巴结转移组的层 黏连蛋白的表达率显著高于淋巴结转移组(P<0.05),整合素β1在淋巴结转移组表达率显著高于无转移组(P< O.05)。结论 细胞外基质和整合素β1在非小细胞肺癌组织中有高表达;层黏连蛋白高表达可能提示肿瘤恶性程 度较低及淋巴结转移发生低,并与鳞癌发生有关;Ⅳ型胶原蛋白高表达可能与腺癌发生有关;整合素β1高表达则可 能促进癌细胞侵袭转移。 Objective Objective To study the expressing features and significance of extracellular matrix (ECM) such as fibronectin, collagen IV, laminin and integrinβ1 in human non-small cell lung cancer(NSCLC). Methods Expression of ECM and integrinβ1 in 57 NSCLC specimens were evaluated by immuno-histochemistry (Envision's method). Results In NSCLC specimens, extensive expression (≥50 % of section area)of fibronectin , collagen Ⅳ and laminin were 80.7 %, 71.9 % and 42, 1% respectively , positive expression of integriβ1 was 43.9 %. The expression rates of fibronectin, collagen Ⅳ, laminin and integrinβ1 in 57 NSCLC specimens were significantly higher than that in 23 normal lung specimens (P〈0.05). The expression rate of laminin in well and moderately differenciated NSCLC specimens was higher than that in poorly differenciated ones(P 〈 0.05). Collagen Ⅳ was more often seen in adenocarcinoma specimens than in squamous cell carcinoma ones(P〈 0.05). Laminin was more frequently seen in squamous cell carcinoma specimens than in adenocarcinoma ones(P〈 0.05). The expression rate of laminin with lymph nodes metastasis was lower than that without lymph nodes metastasis and the expression rate of integrinβ1 with lymph nodes metastasis was higher( P 〈 0.05). Conelusion ECM and integrinβ1 were highly expressed in NSCLC. It was likely that over-expression of laminin imply low malignancy , lymph nodes metastasis and was associated with the occurrence of squamous cell carcinoma. Over-expression of collagen Ⅳ might be related to the occurrence of ad lnVaslveness Over-expression of integrinβ1 might promote tumor cell invasiveness.
作者 徐妍 周彩存
出处 《同济大学学报(医学版)》 CAS 2005年第5期40-44,共5页 Journal of Tongji University(Medical Science)
基金 上海市科委基金资助项目(034119953)
关键词 非小细胞肺癌 细胞外基质 整合素Β1 免疫组织化学 non-small cell lung cancer(NSCLC) extracellular matrix(ECM) integrinβ1 immuno-histochemistry
  • 相关文献

参考文献9

  • 1Rintoul RC, Sethi T. Extracellular matrix regulation of drug resistance in small-cell lung cancer [J ]. Clin Sci,2002,102(4) :417 - 424.
  • 2Han JY, Kim HS, Lee SH, et al. Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis[J]. Lung Cancer,2003,41(1) :65 -70.
  • 3Ioachim E, Charchanti A, Bruasoulis V, et al. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type Ⅳ and la minin in breast cancer: their prognostic value and role in tumor invasion and progression[J]. Eur J Cancer, 2002,38(18):2362 - 2370.
  • 4Jayne DG, Heath RM, Dewhurst O, et al. Extracellular matrix proteins and chemoradiotherapy: α5β1 integrin a predictive marker in rectal cancer[J]. Eur J Surg Oncol,2002,28(1) : 30 - 36.
  • 5Hidenori M,Tatsuya M,Kunihiro T, et al. Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins[J ]. Pancreas,2004,28(1) :38 - 44.
  • 6Sethi T,Rintoul RC, Moore SM, et al.Extracellular matrix proteins protect small cell lung cancer cells against apoptosis:a mechanism for small cell lung cancer growth and drug resistance in vivo[J ]. Nat Med, 1999,6 (5):662 - 668.
  • 7Terol M J, Lopez-Guillermo A, Bosch F, et al. Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive feature [J ]. J Clin Oncol, 1999,17(6): 1869- 1875.
  • 8Dalton WS. The tumor microenviroment: focus on myeloma[J]. Cancer Treat Rev,2003,29(Suppl: 1): 11 - 19.
  • 9Buttery RC, Rintoul RC, Sethi T. Small cell lung cancer:the importance of the extracellular matrix [ J ]. Int J Biochem & Cell Biol,2004,36(7) :1154 - 1160.

同被引文献41

  • 1韩明权,刘嘉湘,高虹,朱晏伟,陈善香.24味中药对人肺腺癌细胞核酸和蛋白质及细胞周期的影响观察[J].中国中西医结合杂志,1995,15(3):147-149. 被引量:66
  • 2李汾,弥曼,袁秉祥.中药多糖的非免疫抗肿瘤作用机制[J].现代肿瘤医学,2006,14(6):748-750. 被引量:7
  • 3王维民,刘延庆.单味中药提取物抗肿瘤实验研究进展[J].江苏中医药,2006,27(6):63-65. 被引量:5
  • 4苏春霞,周崧雯,易祥华,周彩存.细胞外基质在非小细胞肺癌中的表达及与新辅助化疗的关系[J].肿瘤,2007,27(6):462-464. 被引量:1
  • 5JUNG Y D,AHMAD S A,LIU W, et al. The role of the microenvironment and intercellular cross-talk in tumor angiogenesis[ J]. Semin Cancer Biol, 2002,12(2 ) : 105-112.
  • 6KENNETH H S, WILLIAM S D. Cell adhesion is a key determinant in de novo multidrug resistance (MDR) : new targets for the prevention of acquired MDR[ J]. Mol Cancer Ther,2001, 1 ( 11 ) : 69-78.
  • 7RINTOUL R C, SETHI T . Extraeellular matrix regulation of drug resistance in small-cell lung cancer[J]. Clin Sci, 2002, 102(4) : 417-424.
  • 8LUNT S J, CHAUDARY N, HILL R P. The tumor microenvironment and metastatic disease [ J ]. Clin Exp Metastasis, 2009,26 ( 1 ) : 19-34.
  • 9CHERESH D A,STUPACK D G. Regulation of angiogenesis : apoptotic cues from the ECM [ J ]. Oncogene, 2008, 27 ( 48 ) : 6285- 6298.
  • 10HAN J Y,KIM H S,LEE S H,et al. Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis [ J]. Lung Cancer,2003,41 ( 1 ) :65-70.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部